Nanoparticles designed to harness transcytosis achieve deeper tumour penetration.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy
Acta Pharmacologica Sinica Open Access 21 April 2020
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Minchinton, A. I. & Tannock, I. F. Nat. Rev. Cancer 6, 583–592 (2006).
Chauhan, V. P. & Jain, R. K. Nat. Mater. 12, 958–962 (2013).
Komarova, Y. & Malik, A. B. Annu. Rev. Physiol. 72, 463–493 (2010).
Fung, K. Y. Y., Fairn, G. D. & Lee, W. L. Traffic 19, 5–18 (2018).
Tuma, P. L. & Hubbard, A. L. Physiol. Rev. 83, 871–932 (2003).
Zhou, Q. et al. Nat. Nanotechnol. https://doi.org/10.1038/s41565-019-0485-z (2019).
Ferrari, A. et al. Mol. Ther. 8, 284–294 (2003).
Nguyen, S. et al. mBio 8, e01874–01817 (2017).
Predescu, D., Predescu, S. & Malik, A. B. Proc. Natl Acad. Sci. USA 99, 13932–13937 (2002).
Ayloo, S. & Gu, C. Curr. Opin. Neurobiol. 57, 32–38 (2019).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Jang, H.L., Sengupta, S. Transcellular transfer of nanomedicine. Nat. Nanotechnol. 14, 731–732 (2019). https://doi.org/10.1038/s41565-019-0494-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41565-019-0494-y
This article is cited by
-
Thiol-mediated transportation pathway: an approach for improving tumor penetration of nanomedicines in vivo
Science China Chemistry (2024)
-
Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy
Acta Pharmacologica Sinica (2020)